ArticleJournal of immunology research2022

PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer.

Jing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.